AngioDynamics, Inc.
ANGO
$9.49
-$0.11-1.15%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.23% | -7.88% | -14.22% | -22.06% | -6.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.23% | -7.88% | -14.22% | -22.06% | -6.85% |
| Cost of Revenue | -15.70% | -15.13% | -20.33% | -33.88% | -2.21% |
| Gross Profit | 8.35% | -0.88% | -8.33% | -10.66% | -11.46% |
| SG&A Expenses | 0.12% | 3.67% | -4.16% | -4.08% | 5.07% |
| Depreciation & Amortization | -20.96% | -28.07% | -29.10% | -41.58% | -30.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.37% | -9.17% | -13.81% | -14.82% | 0.86% |
| Operating Income | 42.68% | 24.45% | 10.47% | -256.88% | -117.52% |
| Income Before Tax | 97.79% | 14.03% | -136.33% | 35.33% | -1,966.85% |
| Income Tax Expenses | 99.98% | -100.67% | 101.21% | -73.87% | -6,606.15% |
| Earnings from Continuing Operations | 97.65% | 63.03% | -127.89% | 37.35% | -1,879.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.65% | 63.03% | -127.89% | 37.35% | -1,879.29% |
| EBIT | 42.68% | 24.45% | 10.47% | -256.88% | -117.52% |
| EBITDA | 91.93% | 6,996.15% | 36.69% | -182.82% | -262.65% |
| EPS Basic | 97.69% | 63.67% | -127.34% | 38.62% | -1,843.40% |
| Normalized Basic EPS | 90.66% | 23.63% | 18.03% | -137.06% | -85.10% |
| EPS Diluted | 97.64% | 63.67% | -127.37% | 37.88% | -1,845.02% |
| Normalized Diluted EPS | 90.66% | 23.63% | 17.76% | -137.06% | -85.10% |
| Average Basic Shares Outstanding | 1.54% | 1.75% | 2.04% | 2.07% | 1.84% |
| Average Diluted Shares Outstanding | 1.54% | 1.75% | 1.71% | 2.07% | 1.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |